Background/Aims: Upon Ca 2+ store depletion, stromal interaction molecule 1 (STIM1) oligomerizes, redistributes near plasmalemma to interact with Ca 2+ selective channel-forming subunit (Orai1) and initiates store-operated Ca 2+ entry (SOCE). Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) is a regulator of SOCE, but how CaMKII regulates SOCE remains obscure. Methods: Using Fura2, confocal microscopy, co-immunoprecipitation, specific blocker and overexpression/knockdown approaches, we evaluated STIM1 aggregation and its interaction with Orai1, and SOCE upon Ca 2+ store depletion in thapsigargin (TG) treated HEK293 and HeLa cells. Results: Overexpression of CaMKIIδ enhanced TG-induced STIM1 colocalization and interaction with Orai1 as well as SOCE. In contrast, CaMKIIδ knockdown and a specific inhibitor of CaMKII suppressed them. In addition, overexpression or knockdown of CaMKIIδ in TG treated cells exhibited increased or reduced STIM1 clustering and plasmalemma redistribution, respectively. Conclusion: CaMKII up-regulates SOCE by increasing STIM1 aggregation and interaction with Orai1. This study provides an additional insight into SOCE regulation and a potential mechanism for CaMKII involvement in some pathological situations through crosstalk with SOCE.
Introduction
Store-operated Ca 2+ entry (SOCE) is a common Ca 2+ entry mode in excitable and nonexcitable cells. This Ca 2+ influx not only delivers Ca 2+ to refill sarcoplasmic/endoplasmic reticulum (SR/ER) Ca 2+ stores after depletion, but also acts as a Ca 2+ signal to regulate a variety of cellular events, including gene expression, cell growth, proliferation, migration and apoptosis [1] [2] [3] [4] . It is well accepted that the assembling of stromal interaction molecule 1 (STIM1) towards Ca 2+ selective channel-forming subunit (Orai1) in plasma membrane (PM) is the fundamental mechanism to drive SOCE. Upon depletion of ER Ca 2+ stores, STIM1 senses the lowered ER Ca 2+ levels via its luminal Ca
2+
-binding E-F hand, and then oligomerizes and translocates to membrane contact junctions between the ER and the PM, thus displaying distinct STIM1 puncta. At the same time, Orai1 accordingly redistributes in the PM and interacts with STIM1 to trigger SOC channel opening [5, 6] .
Although the basic molecular mechanisms of SOCE activation and the contributing proteins are well understood, the regulatory mechanisms involving the interaction of STIM1 with Orai1 and the fine-tuned modulation of SOCE are quite complicated and far from clear [7] . Several regulators of STIM1/Orai1 complex, such as septins, surfeit locus protein, Ca 2+ release-activated Ca 2+ channel regulator and store-operated Ca 2+ entry-associated regulatory factor, have been proposed [8] [9] [10] [11] . We also find a down-regulatory mechanism for SOCE through calsequestrin-1, a Ca 2+ binding protein inside SR/ER, interacting with STIM1 [12, 13] . In addition, calmodulin (CaM) and kinases including mitogen-activated protein kinase and AMP-activated protein kinase have been demonstrated to affect Orai1 and STIM1 phosphorylation and the following SOCE [14] [15] [16] . Ca
/CaM-dependent protein kinase II (CaMKII) represents a family of serine/threonine (Ser/Thr) protein kinases encoded by four different genes called CaMKIIα, β, γ and δ, which exist as an assembly of monomers found in different tissues. When Ca 2+ rises, Ca
/CaM binds to the regulatory segment of CaMKII and triggers its conformational change, making Thr287 available for phosphorylation for CaMKII activation [17, 18] . CaMKII is a paramount regulator of multiple Ca 2+ handling proteins and ion channels. In physiological conditions, CaMKII activation leads to increases in the open probability and Ca 2+ window current via phosphorylating ryanodine receptor [19] and L-type Ca 2+ channel [20] . Its activation also inhibits Ca 2+ uptake into the SR via phosphorylation of phospholamban and inhibition of SR Ca
-pump ATPase [21] . Under pathological settings, CaMKII has been implicated to be involved in melanoma cell migration/metastasis [4] , cardiomyocyte hypertrophy [22] and neointima formation after vascular injury [23] through SOCE. However, the exact role of CaMKII in regulation of SOCE remains largely unknown. Here, we found that CaMKII upregulates SOCE through enhancing STIM1 aggregation near PM and interaction with Orai1 upon stores depletion in HEK293 cells and HeLa cells, two cell lines widely used in the investigation of SOCE.
Materials and Methods

Reagents and antibodies
Lipofectamine 2000, rProtein G beads, Fura2-AM, Alexa Fluor dye-conjugated secondary antibodies were purchased from Life Technology. Phospho-CaMKII pThr287 antibody (MA1-047) and Super Signal West Pico enhanced chemiluminescence reagents kit were from Thermo Scientific (MA, USA). Rabbit polyclonal CaMKII delta antibody (GTX111401) was from Gene Tex, Inc (CA, USA). Thapsigargin (TG), formaldehydrate solution, and protease inhibitor cocktail were from Sigma-Aldrich (St. Louis, MO, USA). KN-93 and KN-92 were from Merck Millipore (Billerica, MA, USA). Anti-phosphoserine antibody (Ab17465) was from Abcam (Cambridge, USA). All of the antibodies including mouse monoclonal anti-GAPDH (sc-365062), mouse monoclonal anti-STIM1 (SC-166840), rabbit polyclonal anti-STIM1 (SC-68897), mouse monoclonal antiOrai1 (SC-377281), goat anti-mouse IgG-HRP (SC-2005) and goat anti-rabbit IgG-HRP (SC-2004) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Anti-HA was bought from Cell Signal Tech (CST3724T).
Cell culture HEK293 cells and HeLa cells were obtained from ATCC and were cultured at 37°C in Dulbecco's modified Eagles medium (DMEM, Gibco, Rockville, MD, USA) containing 10% fetal bovine serum (FBS, Hyclone, AUS) in humidified 95% air and 5% CO 2 incubators.
Plasmids and cell transfection
Plasmids were constructed by ViGene Biosciences Inc. (Rockville, MD, USA). Overexpression of HAtagged human CaMKIIδ was generated by PCR. Each cDNA was cloned into the pDEST-EGFP expression vector and HA-tag was inserted into C-terminal of CaMKII. HEK293 cells and HeLa cells were transfected with CaMKIIδ through Lipofectamine 2000 reagent as previously described [12] .
Small interfering RNA-based experiment
Small interfering RNAs (siRNAs) targeting CaMKIIδ gene was designed and synthesized by Invitrogen (Carlsbad, CA, USA), and the effect of CaMKIIδ-siRNA was identified by Western blot. The sense sequence of siRNA is as follows: 5′-GGGAUGGAUUUUCACCGAUtt-3′. Scrambled RNA oligonucleotides were used as control. HEK293 cells and HeLa cells in 6 cm dishes were transfected with 40 nM siRNA oligonucleotides using Lipofectamine 2000 reagent (Invitrogen, Life Technologies) according to the manufacturer's instructions. The medium was replaced with Dulbecco's Modified Eagle's medium containing 10% fetal bovine serum after 8 h, and cells were further cultured for 48 h.
Co-immunoprecipitation and western blotting
Co-immunoprecipitation was carried out as previously described [12] . Western blotting was performed as following: The extraction of cell protein was prepared by washing the cells with phosphate-buffered saline (PBS) and then lysing the cells in RIPA buffer, containing 1 mM PMSF and protease inhibitor cocktail for 30 min on ice. Protein samples were heated by incubation in loading buffer for 5 min at 95°C, resolved on a 10% SDS-PAGE and transferred to nitrocellulose membranes. The membranes were subsequently blocked for 1 h at room temperature in 5% non-fat milk. The primary antibodies used for STIM1, Orai1, CaMKIIδ, p-CaMKII at Thr287, and GAPDH were at ratio of 1:1000, 1:500, 1:1000, and 1:1000, 1:1500, respectively, with an overnight incubation at 4°C. The horseradish peroxidase-conjugated secondary antibodies were all diluted at 1:1000 with room temperature for 1 h. Immunoreactive bands were exposed using enhanced chemiluminescence reagents and intensity of each band was normalized with GAPDH.
Immunofluorescence
Cells were plated on 5 x 5 mm cover slides in 6 well plates (5 x 10 4 cells per well). After 24 h culture and plasmids transfected for 48 h, the cells stimulated with 1 μM thapsigargin (TG) plus 2 μM ionomycin for 5 min in Ca
2+
-free medium (the addition of ionomycin can cause more obvious STIM1 conformation and colocolization with Orai1 observed by microscope [12] ), and were fixed in PBS containing 4% paraformaldehyde for 20 min. Then cells were permeabilized by 0.1% Triton X-100 in PBS for 30 min and blocked in 5% bovine serum albumin for 1 h at room temperature. The anti-STIM1, anti-Orai1 and anti-HA antibodies were used at a dilution of 1:50, 1:50, and 1:1000, and the secondary antibody Alexa Fluor 594-labeled goat anti-mouse and Alexa Fluor 488-labeled donkey anti-rabbit used at a dilution of 1:750, respectively. Hoechst 33342 was used to label the nucleus for 10 min at room temperature. The laser-scanning confocal microscope was used to detect the chemifluorescent as previously described [12, 13] . After mounting, a 3-D z-stack was obtained at 0.5 μm intervals by Leica SP8 microscopy equipped with a 63x oil immersion objective (NA 1.4), pinhole=1.0 μm for measurement of co-localization of STIM1 with Orai1. The Pearson's coefficient values that represent the degree of co-localization were categorized as strong (0.49-1.0), moderate (0.1-0.48) and weak (−1 to 0.09) based on previous description [24, 25] . ] i ) and Mn 2+ quenching measurements were carried out as previously described [12, 26] . For drug treatment, KN-93 was presented during the cell washes and incubation in Ca Chemical cross-linking HEK293 cells were detached by centrifugation at 200 g for 1 min and resuspended in HBSS. Cells were then cross-linked with 1% (w/v) formaldehyde solution for 5 min. The cross-linking reaction was terminated with a final concentration of 0.1 M glycine stock solution and the incubation was continued for 5 min at 4°C. After centrifuging at 200 g for 1 min and washing 3 times with ice-cold HBSS, cells were lysed with lysis buffer, containing 1% SDS, 0.1% Triton-X100, 1 mM PMSF and protease inhibitor cocktail under constant agitation at 4°C for 5 min. Then the lysates were centrifuged at 4°C, 15000 g for 15 min and the supernatants were collected for Western blotting without boiling before loading in the comb hole based on previous description [12, 27] .
Measurement of cytosolic
Statistical analysis
All data present as means ± SD, and n indicates independent experiments. Statistical analyses in each response were performed using Student's t-test or one-way analyses of variance (ANOVA). P<0.05 was considered statistically significant.
Results
Inhibition of CaMKII attenuates SOCE SOCE was induced in Fura2 loaded cells by thapsigargin (TG, 1 μM) in Ca
2+
-free medium for 5 min followed by Ca 2+ addition into the medium. Pretreatment of the cells with 5 or 10 μM KN93 for 10 min, to block CaMKII [17] [18] [19] [20] [21] , significantly inhibited the first peak and the following plateau of Ca 2+ influx induced by TG in both HEK293 ( Fig. 1A and B) and HeLa cells ( Fig. 1D and E), while the Ca 2+ release phase remained unaltered. The relative Ca 2+ entry -free solution and Ca 2+ influx following the addition of 1.8 mM Ca 2+ were induced by TG. Statistical data show the average peaks±SD of Ca 2+ release, Ca 2+ influx peak and plateau (at 700 s, B and E), and SOCE quantity within the initial 50 s or 200 s in response to TG (C and F). N=5-6 independent experiments for each bar. * and ** represent P<0.05 and P<0.01 vs. control, respectively, analyzed by Student's t-test. , representing the fast and slow Ca 2+ entry phase respectively [12] , were also decreased because of KN93 treatment ( Fig. 1C and F) . However, the pretreatment of cells with KN92 (10 μM), an inactive chemical analog of KN93, showed no effect on SOCE.
Furthermore, SOCE was assessed by quenching the intracellular Fura2 fluorescence via the entry of extracellular Mn 2+ to eliminate possible influence of Ca 2+ transport mechanism. Compared with control, the maximum Mn 2+ quenching due to TG was significantly reduced in the presence of 10 μM KN93, but not 10 μM KN92 ( Fig. 2A and B) . As CaMKIIδ is widely expressed in various tissues, and its activation is manifested by phosphorylation at Thr287 [17] [18] [19] , we then detected CaMKIIδ activity by assessing Thr287 phosphorylation with a specific antibody. TG treatment could promote CaMKII phosphorylation at Thr287, while pretreatment of cells with KN-93 at the concentration inhibiting SOCE prevented the increased Thr287 phosphorylation due to TG in both types of cells ( Fig. 2C and D) . Therefore, these results may suggest that the endogenous CaMKII is activated upon TG stimulation, and as a result, is involved in the regulation of SOCE in both HEK293 and HeLa cells.
Change in CaMKII expression affects SOCE
To further address the issue of CaMKII activity on SOCE, we determined the effects of knocking down the endogenous CaMKIIδ and increasing its expression on SOCE. The abundance of CaMKIIδ expression in HEK293 and HeLa cells interfered with CaMKIIδ-siRNA or transfected with plasmid encoding HA-tagged human wild-type CaMKIIδ gene were examined. By detecting the green fluorescent protein, we found a ＞90% transfection efficiency in both HEK293 and HeLa cells treated with the plasmid at concentration of 2 μg/ml for 48 h, thus, we used this concentration in all the following examinations. Compared with counterpart controls, cells treated with CaMKIIδ-siRNA displayed a significant decrease in CaMKIIδ expression (46.3±14.2% of control), while cells transfected with CaMKIIδ-wt showed an approximately a 6-fold increase in CaMKIIδ expression; STIM1 and Orai1 expressions remained unchanged in both CaMKIIδ manipulated cells (Fig. 3A and B) . Accordingly, compared with control cells, the peak, the plateau and the relative quantity of Ca 2+ influx induced by TG were significantly inhibited in CaMKIIδ knockdown but enhanced in CaMKIIδ overexpressed HEK293 cells (Fig. 3C-E ) and HeLa cells (Fig. 3F-H) , while their Ca 2+ release phases were not affected. Here, we used 0.5 μM TG, because the potential effect of CaMKII on SOCE was 
CaMKII Regulates SOCE more significant in 0.5 μM than 1 μM TG treated cells, especially for HeLa cells. Similarly, the rate of Mn 2+ quenching was also promoted in CaMKIIδ overexpressed cells and decreased in CaMKIIδ deficient cells (data not shown). Thus, the effect of manipulating CaMKIIδ expression supports the notion that CaMKII activation up-regulates SOCE.
CaMKII affects STIM1 interaction with Orai1
It is well accepted that upon store depletion, STIM1 oligomerizes, translocates to the ER-PM contact junctions, and interacts with Orai1 to trigger SOC channel opening [5] [6] [7] . Thus, STIM1 and Orai1 association was measured by evaluating STIM1 co-localization with Orai1 in whole cell using Imaris Bitplane software. This quantitative measurement can give an overlap degree presented by the Pearson correlation coefficient between fluorescence signals acquired in two channels [12, 13, [24] [25] [26] . We found an approximately 2-fold increase in STIM1 and Orai1 co-localization on PM of cells after TG (1 μM)+ionomycin (2 μM)-treatment for 5 min in Ca
2+
-free medium compared with control cells, but this increased co-localization was prevented by pretreatment of the cells with KN-93, but not with KN-92 ( Fig. 4A and  B) . In contrast, CaMKIIδ-overexpression cells treated with TG exhibited an increase in the Pearson correlation coefficient of STIM1/Orai1 compared with that of control cells (Fig. 4C  and D) . To avoid the variation in cells selection for 3-D scanning and calculation of Pearson coefficient, here we added ionomycin because more uniformed STIM1 oligomerization and translocation near PM was found in most of the cells in a dish than 1 μM TG stimulated alone [28, 29] . To further verify the influence of CaMKII on the association of STIM1 with Orai1, we carried out co-immunoprecipitation experiment using specific antibody for STIM1 or Orai1. We found that STIM1 co-immunoprecipitated with Orai1 after TG stimulation for 5 min, and this interaction was partially prevented due to the pretreatment of cells with KN-93, but not with KN-92, at the concentration inhibiting Ca 2+ entry (Fig. 5A-C) . Knocking down the endogenous CaMKIIδ expression reduced STIM1/Orai1 physical interaction, whereas overexpressing CaMKIIδ increased their association after TG stimulation in both types of cells (Fig. 5D-F) .
CaMKII enhances STIM1 aggregation
To further investigate how CaMKII regulates SOCE, STIM1 aggregation and trafficking towards cell surface upon store depletion were examined by immunostaining STIM1 alone to avoid possible influence of Orai1 labeled fluorescence and calculating STIM1 puncta at the size of 0.5-1 μm that are usually taken as STIM1 aggregation when store depleted [5] [6] [7] 30] . We calculated the STIM1 clusters in whole cell (excluding the nuclear area) and the perimembranous region (from membrane surface to 1.0 μm inside) using Imaris Bitplane software in cells from 3-D stack images (Fig. 6A) [12, 13] . A dramatic increase in STIM1 clustering in whole cell and, in particular, the perimembranous area (16.5 times vs. 8.9 times in cytosolic area) was found after TG stimulation. While pretreatment of the cells with KN-93 or CaMKIIδ-siRNA reduced STIM1 clustering in both areas, CaMKIIδ overexpression significantly increased the STIM1 aggregation upon store depletion (Fig. 6A and B) . Moreover, to avoid possible interference of the non-transfected cells that might be mistaken as CaMKIIδ-positive cells, double-staining the overexpressed cells with antibodies against HA-CaMKIIδ and STIM1 was carried out. Subconfluent (used in the measurements of internal Ca 2+ and Furthermore, STIM1 aggregation was assessed by cross-linking approach with 1% formaldehyde to detect monomers, dimers and polymers. TG caused a reduction in monomers accompanied by an increase in dimmer/polymer forms as already known [5] [6] [7] [8] . Unlike cell treated with KN-92, cells treated with KN-93 or CaMKIIδ-siRNA displayed decreased STIM1 aggregation, while cells with CaMKIIδ overexpression showed an increase in dimers/ polymers with a decrease in monomers compared with counterpart controls (Fig. 7A) .
Finally, the total STIM1 phosphorylation at serine sites was detected to assess if STIM1 phosphorylation was accordingly changed in TG-stimulated cells with different CaMKIIδ manipulation. Here, a pull-down experiment was performed by STIM1 antibody, and a specific anti-phosphoserine antibody was used to detect STIM1 phosphorylation. An increase in Serphosphorylation was found in HEK293 cells after TG stimulation, which was down-regulated in CaMKIIδ-knockdown cells, but up-regulated in CaMKIIδ-overexpressed cells (Fig. 7B) .
Discussion
CaMKII is an important Ca 2+ regulatory protein for intracellular Ca 2+ homeostasis [17] [18] [19] [20] . Many studies have shown that CaMKII inhibition causes suppression of SOCE in various types of cells [4, 22, 23, 31, 32] . However, some studies also demonstrate a potentiated effect of CaM and CaMKII inhibition on SOCE [16, 33, 34] . In the present study, we found that pharmacological and siRNA interventions of CaMKII inhibit SOCE, while overexpression of CaMKIIδ up-regulates SOCE in HEK293 and HeLa cells (Figs. 1-3 ). In addition, STIM1 punctuation and co-localization/interaction with Orai1 were affected by CaMKII inhibition and CaMKIIδ overexpression (Figs. 4 and 5) . Furthermore, STIM1 serine phosphorylation and oligomerization/redistribution onto plasma membrane, and interaction with Orai1 were also altered in accordance to the CaMKII changes [Figs. 6 and 7] . Therefore, these data suggest that CaMKII up-regulates SOCE, at least partly, through targeting STIM1 conformation and interaction with Orai1. Previous reports have mechanically described that CaMKII activation potentiates SOCE by altering SOC channel gating in Xenopus oocytes [31] or enhancing SOC current in multiple types of cells [22, 35] . In accordance with the assessment in SOC channel, we also observed corresponding Ca 2+ influx change, the final outcome like SOC current in SOCE activation, upon store depletion in different CaMKII manipulated cells. Importantly, we further demonstrated an up-regulation of STIM1 clustering and translocation to plasmalemma by CaMKII, thus activating SOCE.
Physiologically, a small increase in cytosolic Ca 2+ is sufficient to active CaM and CaMKII, which then provides feedback regulation on Ca 2+ signal. For instance, activation of CaM upon Ca 2+ rise acts in concert with STIM1 and the N terminus of Orai1 to evoke rapid SOCE inactivation in many types of cells [16, 34, 36] , playing as a down-regulator of SOCE. In contrast, CaMKII activation usually enhances Ca 2+ signaling; such as promoting ryanodine receptor and L-type Ca 2+ channel activation in cardiomyocytes [19] [20] [21] , as well as enhancing SOCE in non-excitable cells [4, 31, 35] . Moreover, CaMKII can be auto-activated in pathological situation [17, 37] . Therefore, the key players, CaM and CaMKII, in Ca
2+
/CaM/CaMKII pathway can regulate Ca 2+ signaling independently through CaMKII auto-activation or cooperatively through internal Ca 2+ increase and act on different target proteins and pathways [17, [34] [35] [36] [37] , rendering much complicated and fine-tuned Ca 2+ activities to fit various biological needs in cellular function.
Studies under pathological settings further support up-regulated SOCE by CaMKII. Numerous studies have characterized that Ca 2+ -handling abnormalities including spontaneous ventricular tachycardia [19, 21] , myocardial hypertrophy [22, 38] , heart failure [39] , neointima formation [23] , tumor cell migration/metastasis [4] and cell death [40] are resulted from an increase in CaMKII activity. Similarly, dysfunction of SOCE has been found in diabetic platelets [41, 42] , tumor metastasis [43] , chondrocyte autophagy [44] , and cardiac hypertrophy and arrhythmias [23, 45] . Importantly, some studies have implicated that enhanced CaMKII and SOCE activities are associated with pathological changes [4, 22, 23] . This study provides a direct physiological link between CaMKII and SOCE, and a potential insight into the disturbed Ca 2+ signaling in pathological condition through their crosstalk. STIM1 oligomerization triggered by ER Ca 2+ store depletion is an initial step for SOCE activation. The molecular motif that controls the primary trigger for oligomerization appears to reside in the luminal EF-SAM domains [46] . Once STIM1 oligomerizes, the clustered STIM1 translocates towards the ER-PM junctions and aggregates into puncta. Several phosphorylated residues in STIM1 were found in response to epidermal growth factor stimulation in HeLa cells, but the more detailed physiological connection of these phosphorylations with STIM1 function in SOCE activation remains impalpable [14, 15] . Recent studies have revealed that SOCE is inhibited by phosphorylation of STIM1 in nonexcitable cells [15, 47] . Some studies have demonstrated that the phosphorylation of STIM1 in ERK1/2 target serine residues is essential to fully trigger SOCE [14] . Therefore, the exact role of different phosphorylation sites is complicated. In this study, TG treatment increased Ser-phophorylation of STIM1, which was blunted in CaMKII-knockdown cells but enhanced in CaMKII-overexpressed cells, suggesting that CaMKII regulates STIM1 Ser-phosphorylation upon TG stimulation. Therefore, STIM1 phosphorylation at serine sites by CaMKII should be an intermediate process involved in its regulation of SOCE.
Conclusion
This study demonstrates a novel mechanism for CaMKII regulating Ca 2+ influx through SOC channel. Upon Ca 2+ store depletion, CaMKII is activated and up-regulates SOCE via 
